Skip to content
Offline

Innate Pharma

🇫🇷XPAR.IPHFranceHealthcare

€1.56EURup +0.01 (+0.65%)ClosedEnd of day10:38 PM
OverviewAnalysisbetaPrice ChartFinancialsRevenue StreamsNot available for this exchange yetAnomaliesNewsNot available for this exchange yetInvestorsNot available for this exchange yetCorporate Actions

Price€1.56+0.01 (+0.65%)

Profile

  • Healthcare
  • Biotechnology
  • France

Identity

Exchange
Euronext Paris . XPAR
Type
Stock
ISIN
FR0010331421
CUSIP
Not reported

Company

Employees
164
Headquarters
Marseille, United States
Website
https://www.innate-pharma.com
CEO
Mr. Jonathan E. Dickinson B.Sc., M.B.A.

Market

Shares outstanding
92.2M
Market cap
€143.8M

Key dates

Next earnings
Sep 17, 2026

Highlights

Day range€1.53 - €1.57
today's session
52-week range€1.03 - €2.33
from 255 sessions
Market cap
€142.88M
EPS LTM
-€0.57
P/E LTM
-1.86
Div yield
Not reported

Fundamentals (LTM)

Revenue
€714K
Net income
-€52.1M
Gross margin
-2,773.95%
Free cash flow
-€48.35M

View all financials

Other listings

These are the venues Finzer covers, not every venue that exists.

Business summary

No company summary reported yet.

Cookies and analyticsWe measure how the site is used. Without your agreement we count you anonymously and store nothing on your device. Accept to let us link that to your account, so we can improve what you actually use. We never send personal data either way.We count visits anonymously. Accept to link them to your account. Privacy Policy